Allarity Therapeutics Inc. (ALLR)
Market Closed
30 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 23
+0.07
+6.0345%
$
20.37M Market Cap
0 P/E Ratio
- Div Yield
55,393 Volume
-205.83 Eps
$ 1.16
Previous Close Investors:
Want to track ALLR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Allarity Therapeutics Inc. (ALLR) Statistics
Valuation metrics
Market Cap 20.37M
Enterprise value 20.62M
Trailing P/E (ttm) -1.65
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 54.88
Price/Book (mrq) 2.75
Enterprise Value/Revenue 59.76
Enterprise Value/EBITDA -1.88
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 71.03K
Average volume (90 days) 210.53K
Price summary
52-Week low 0.77
52-Week high 2.35
Beta -
50-Day moving average 1.37
200-Day moving average 1.23
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:30
Last split Date 11 Sep 2024
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -32.61%
Operating margin -35.53%
Operational effectiveness
Return on assets -0.32%
Return on equity -1.1%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.7
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.24
Total debt (mrq) -
Total Debt/Equity (mrq) 3.11
Current ratio (mrq) 1.23%
Book value per share (mrq) 0.43
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
